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Abstract The in vitro selection and simultaneous evolution of
proteins is feasible by means of ribosome display. Here, we
describe the use of a protein bearing a binding property without
being an antibody for affinity enrichment of the ternary complex,
consisting of a protein, a ribosome and a encoding mRNA. The
binding property was a simple affinity tag, namely Strep-tag II
and His-tag. We could demonstrate that the selection of a
specific mRNA encoding a shortened bovine heart fatty acid
binding protein with a N-terminal His-tag was possible. After
nine cycles of transcription, translation, affinity selection and
reverse transcription PCR the protein with the His-tag could be
enriched 108-fold. ß 2001 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Nucleic acids with speci¢c molecular recognition and cata-
lytic properties have been identi¢ed from complex pools by
SELEX (reviewed in [1]), since they are simultaneously geno-
type and phenotype. Nonetheless, the selection and directed
evolution of proteins is of great interest, because they play an
essential role in nearly all biological processes and are much
more extensively used in diagnostics, therapeutic, and indus-
trial applications. Most of the methods used for the selection
of proteins as carrier of the phenotype have been based di-
rectly or indirectly on living cells. Examples of such ap-
proaches include phage display [2], plasmid display [3], and
completely in vivo genetic approaches [4^6]. However, in vivo
approaches are limited by transformation e⁄ciency to 1^
10U109 di¡erent molecules. This limitation can be overcome
by using in vitro systems based on cell-free translation. Un-
fortunately, proteins are not genetic molecules and cannot be
copied by any known enzymatic activity. Therefore, to con-
struct an in vitro protein selection cycle, the ampli¢able ge-
nomic information (mRNA) must be physically linked to the
selectable information (protein). Two di¡erent approaches
have been published which make such coupling possible.
The mRNA^protein fusion technique is a covalent linkage
between the 3P-end of the mRNA and the carboxyl terminus
of the protein via puromycin [7]. The puromycin^mRNA fu-
sion has to be repeatedly constructed for each selection cycle
and is a time-consuming factor. The ribosome display is based
on the possibility of expressing proteins from mRNA lacking
a stop codon, and making direct use of the ternary complex,
consisting of a protein, a ribosome and a encoding mRNA
(PRM-complex), for a⁄nity enrichment [8] (Fig. 1). One lim-
itation of the ribosome display is that libraries must be
screened under conditions in which the PRM-complex is sta-
ble (high Mg2 and low temperature). All selections based on
the ribosome display technique reported so far have been
carried out with antibodies. The dissociation constant (kd)
of the selected binding a⁄nities ranges from 0.04 to 10 nM.
We wanted to ¢nd out if it is possible to extend this technique
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Fig. 1. Principle of in vitro ribosome display for screening protein
libraries for ligand binding. (1) A DNA library is ¢rst transcribed
into mRNA. (2) The mRNA lacking a stop codon is template for
an in vitro translation. The formed PRM-complexes are stabilized
by cooling on ice and increasing the magnesium concentration.
(3) The desired PRM-complexes are a⁄nity selected from the trans-
lation mixture by binding to the immobilized ligand. (4) The PRM-
complexes can be eluted with a speci¢c competitor. (5) Dissociation
of the complexes by adding EDTA. (6) RT of the isolated mRNA.
(7) Ampli¢cation of the cDNA by PCR, whereby a T7 promoter is
introduced. This DNA is then used for the next cycle of enrichment
and (8) can be analyzed by cloning and sequencing.
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to other proteins than antibodies, i.e. proteins possessing oth-
er types of a⁄nities. Furthermore, the knowledge about the kd
value essential for selecting PRM-complexes is of great inter-
est. Here, we report the establishment of the ribosome display
technique with a protein carrying an a⁄nity tag.
2. Materials and methods
2.1. Construction of plasmids
Standard methods for molecular biology were used [9]. The plas-
mids pHMFA and pFA+NStII [10] were the starting point for further
constructs. Both have a T7 promoter, a sequence for the 5P untrans-
lated region of phage T7 gene 10 followed by a coding sequence for
FABP and a T7 transcription terminator 150 bp downstream of the
coding sequence. The pFA+NStII additionally has 30 bp encoding a
linker and the Strep-tag II [11] at the N-terminus of the protein. The
two vectors were digested with PstI/BamHI and the hybridized oligo-
nucleotides lpp-for (5P-GCTGACCCGTTTAGAGGCCCCAAGGG-
GTTATGGAATTCACCTTTAAGCAGCTCG-3P) and lpp-rev (5P-
GATCCGAGCTGCTTAAAGGTGAATTCCATAACCCCTTGGG-
GCCTCTAAACGGGTCAGCTGCA-3P) were cloned into them. In
the cause of this process, a modi¢ed lipoprotein terminator (lpp term)
was introduced at the C-terminus of the protein and at the same time,
the stop codon was removed. The resulting plasmids were termed
pFAlpp and pFAlpp+NStII.
Another construct designated pFAlpp+NHis was prepared by PCR
from pFAlpp using the following primer pairs: FAF1 (5P-CGC-
GCGCCATGGTGCATCATCATCATCATCATGTGGACGCCTT-
CGTGGGTACC-3P) and FAR1 (5P-GAAGAGCAGTCAGTGG-
GAGGAGAGGGCAGGTCATGCCTGTTT-3P), which introduces a
single valine followed by a hexahistidyl-tag at the N-terminus of the
protein.
2.2. In vitro transcription
The mRNA transcripts were obtained by in vitro transcription us-
ing PCR products or BamHI-treated plasmids with T7 RNA polymer-
ase (Stratagene) following the protocol of Triana-Alonso et al. [12]
with minor modi¢cations.
The reaction mixtures were incubated for 2 h at 37‡C and contained
80 mM HEPESWKOH (pH 7.5), 22 mM MgCl2, 1 mM spermidine, 20
nM plasmid DNA or 100 nM PCR product, 10 mM DTE, 120 Wg/ml
BSA, 0.4 U/Wl RNase inhibitor (Promega), 5 U/ml inorganic phos-
phatase (Sigma), 1 U/Wl T7 RNA polymerase (Stratagene), 3.75 mM
ATP, CTP, GTP, and UTP. For the radiolabeling of mRNAs the
concentration of CTP was 2 mM and [K-35S]CTP (Amersham) with
a molar activity of s 1000 Ci/mmol was added to a ¢nal concentra-
tion of 0.2 WCi/Wl. After in vitro transcription the reaction mixture
was treated with 0.2 U/Wl RNase-free DNase I (Roche) for 15 min at
37‡C. The transcripts were puri¢ed by phenol extraction followed by
gel ¢ltration with a NAP5 column (Pharmacia) and precipitated with
isopropanol. The pellets were resolved in water. Transcripts were an-
alyzed by agarose gel electrophoresis.
2.3. In vitro translation
The in vitro translation reaction is based on an Escherichia coli S30
lysate (strain D10) and was performed as described [13] with several
modi¢cations. Translation was carried out for 8 min at 37‡C in a 250
Wl reaction mixture that contained the following components: 50 mM
HEPESWKOH (pH 7.6), 70 mM KOAc, 30 mM NH4Cl, 14 mM
MgCl2, 0.1 mM EDTA, 0.02% NaN3, 0.15 mM leucine, 0.4 mM
each amino acid (leucine omitted), 1 mM each of ATP and GTP,
0.5 mM each of CTP and UTP, 30 mM phosphoenolpyruvate, 10
mM acetyl phosphate [14], 4% polyethylene glycol 2000, 20 Wg/ml
rifampicin, 0.1 mg/ml total E. coli tRNA, 100 WM folinic acid, 100
U/ml RNase inhibitor (Promega), 26% (v/v) S30, 0.2^0.6 WM mRNA
and 5 WM anti-ssrA oligonucleotide [8]. 0.2 WM L-[14C]leucine (25
dpm/pmol; Amersham) was added instead of 0.15 mM leucine for
labeling the synthesized proteins.
2.4. Analysis of the synthesized protein
The incorporation of L-[14C]leucine into the synthesized proteins
was determined by liquid scintillation counting of the trichloroacetic
acid-insoluble material as described [15]. The reaction products were
also analyzed by SDS^PAGE [16] followed by an autoradiography in
a ‘Phosphoimager’ system (Molecular Dynamics).
2.5. A⁄nity selection of PRM-complexes and isolation of mRNA
The translation was stopped by cooling on ice, and adding 1 M
Mg(OAc)2 to a ¢nal concentration of 50 mM [8] and dilution bu¡er
(50 mM TrisWHOAc, pH 7.5/150 mM NaCl/50 mM Mg(OAc)2/0.1%
Tween 20) to a ¢nal volume of 625 Wl. The samples were centrifuged
for 5 min at 4‡C at 15 000Ug to remove insoluble components. The
supernatant was applied to a 250-Wl Ni2^iminodiacetic acid (IDA)^
agarose (Novagen) column. After six washes with 500 Wl ice-cold
washing bu¡er (50 mM TrisWHOAc, pH 7.5/150 mM NaCl/50 mM
Mg(OAc)2/5^10 mM imidazole) the retained PRM-complexes were
eluted with 500 Wl ice-cold elution bu¡er (washing bu¡er with 300
mM imidazole). The released PRM-complexes were treated with 0.5
M EDTA until the ¢nal concentration was 50 mM and were precipi-
tated with isopropanol in the presence of 0.3 M NaOAc (pH 5.5) and
40 Wg glycogen. The ‘pellet’ was dissolved in 30 Wl water and used for
reverse transcription (RT).
2.6. Analysis of recovered mRNA after a⁄nity selection
[K-35S]CTP-labeled mRNAs were used to examine the integrity and
amount of mRNA. For electrophoretic analysis 20 Wl of a translation
reaction or comparable amounts of other fractions were incubated for
30 min at 37‡C with 20 mM EDTA, 0.5% SDS and 0.1 g/l proteinase
K. The mRNA was puri¢ed by isopropanol precipitation and sepa-
rated by using a 6% polyacrylamide gel containing 7 M urea, 0.1%
SDS and TBE followed by an autoradiography in a ‘Phosphoimager’
system (Molecular Dynamics).
For TCA precipitation two identical samples of every fraction were
precipitated with 5% TCA [9] and quanti¢ed by scintillation counting.
2.7. RT-PCR
Reverse transcription was performed using Superscript II reverse
transcriptase (Gibco BRL) according to the supplier’s recommenda-
tion with the following primer (5P-CCCCTTGGGGCCTCTAAA-
CGGGTCAGCTGCAGTGCCGTGGGTGAGTGTCAGAATGAG-
TTTCCCGTCAACCATCTCCCG-3P). 30 cycles of PCR were per-
formed using Taq DNA polymerase (Gibco BRL) according to
the supplier’s recommendation using the following primer pair: T7F
(5P-GAAATTAATACGACTCACTATAGGGAGACCACAACGG-
TTTCCCTCTAG-3P), which introduces the T7 promoter, and lppR
(5P-GGATCCGAGCTGCTTAAAGGTGAATTCCATAACCCCTT-
GGGGCCTCTAAACGGG-3P), which introduces the lpp-term. PCR
products were analyzed by agarose gel electrophoresis, puri¢ed from
the gel and directly used for transcription.
3. Results
3.1. Design of mRNAs and their corresponding PCR products
The used mRNAs bear the untranslated region of phage T7
gene 10, which encodes a stem^loop structure at the beginning
of the mRNA, followed by the coding sequence for FABP.
The sequence encoding the last 10 amino acids of FABP and
the stop codon were replaced by the lipoprotein terminator of
E. coli, which encodes a 3P stem^loop at the RNA level.
Therefore, the mRNA is protected against exonucleases at
both ends [8]. The mRNAs obtained by in vitro transcription
from pFAlpp, pFAlpp+NHis and pFAlpp+NStII or the cor-
responding PCR products were designated mFA, mFAHis
and mFAStII, respectively (Fig. 2).
3.2. Formation of PRM-complexes
We started to investigate the formation of PRM-complexes
by translation of mFAStII followed by ultra-centrifugation
(90 min, 250 000Ug, 4‡C) on the assumption of collecting
the PRM-complexes in the pellet and thus separating them
from the mixture. An identical mRNA with stop codon served
as a control. Directly after the translation the PRM-com-
plexes were stabilized by adding Mg(OAc)2 to a ¢nal concen-
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tration of 50 mM and cooling on ice. The amount of synthe-
sized and therefore radioactively labeled protein was mea-
sured in the supernatant and the pellet after ultra-centrifuga-
tion as described. In the approach with mFAStII, nearly 60%
of the synthesized protein were found in the pellet, whereas
only about 33% were detected when using the identical
mRNA with stop codon. On the basis of this experiment
with ultra-centrifugation we ascertained that the translation
lasted 15 min and the amount of anti-ssrA oligonucleotide
was 5 WM.
3.3. A⁄nity isolation of PRM-complexes
The isolation of PRM-complexes with the help of the bind-
ing a⁄nity from the protein portion was tested. Therefore, the
amount of radiolabeled mRNA was measured after a⁄nity
chromatography by TCA precipitation. We tried the Strep-
tag II and the a⁄nity matrix StrepTactin Sepharose [17], since
the puri¢cation of in vitro synthesized proteins works very
well with this system (to be published). The PRM-complexes
from a translation reaction with mFAStII were subjected to a
modi¢ed Strep-tag II a⁄nity chromatography (4‡C, bu¡ers
with 50 mM Mg(OAc)2). The amount of eluted mRNA was
not signi¢cantly higher than the control reaction with
mFAlpp and thus without Strep-tag II.
An in vitro translation with mFAStII under the new con-
ditions was carried out to ensure that the presence of the
PRM-complex is the reason for the non-existing binding ca-
pacity of the protein. One half of the reaction mixture was
treated with Mg(OAc)2 and cooled on ice to stabilize the
PRM-complexes. The other half was incubated at 37‡C for
10 min after adding puromycin to a ¢nal concentration of 5
mM, then also treated with Mg(OAc)2 and cooled on ice.
Puromycin is an antibiotic that mimics the aminoacyl end of
Tyr-tRNA and causes the termination of polypeptide chain
synthesis by entering the ribosomal A site and accepting the
nascent peptide as a result of the peptidyl transferase activity
of the ribosome [18]. The two samples were tested by ultra-
centrifugation and a⁄nity chromatography (Fig. 3). The syn-
thesized protein was radioactively labeled and therefore de-
tectable after TCA precipitation and SDS^PAGE. As ex-
pected, the ultra-centrifugation revealed that the amount of
protein in the pellet was decreased from 75% to 13% after
adding puromycin, whereas it increased in the supernatant
as calculated by TCA precipitation. 22% of the labeled protein
from the sample treated with puromycin was eluted after af-
¢nity chromatography and only 5% of the other sample where
the PRM-complex was stabilized. This result shows that only
the free protein has the potential for binding its a⁄nity ligand
instead of the protein as part of the complex. All the achieved
results are only an indirect proof of the existence of the PRM-
complex, but its in£uence on the loss of binding to the a⁄nity
matrix seems to be obvious. We think that the binding a⁄nity
of the Strep-tag II is not su⁄cient for isolating the whole
PRM-complex. The Strep-tag II was developed to purify pro-
teins in the native state under very mild bu¡er conditions due
to the fact that its kd is only 1 WM [17]. The achieved results
with the Strep-tag system for puri¢cation of in vitro synthe-
sized proteins are very satisfying, but the isolation of the
PRM-complex with approximately 2700 kDa requires a stron-
ger binding a⁄nity.
One of the most widely used tags for protein puri¢cation
with a strong binding a⁄nity is the hexahistidyl tag (His-tag).
Its imidazole moieties can chelate the free coordination sites
of Ni2 ions which are themselves immobilized as chelate
complexes of IDA or nitrilotriacetic acid (NTA) bound to a
solid support [19]. An in vitro translation with 0.1 WM radio-
labeled mFAHis followed by a⁄nity isolation of the PRM-
complex on Ni2^IDA^agarose showed that more than 3% of
the mRNA were eluted. On the other hand, the control reac-
tion with mFA showed about 1.4% mRNA in the elution
fraction. This result revealed that basically, the isolation of
Fig. 2. Schematic drawing of a PCR product and its corresponding
mRNA used for ribosome display. T7 denotes the T7 promoter,
RBS the ribosome binding site, which is part of the untranslated re-
gion of phage T7 gene 10. StII and His6 indicate the presence of
the Strep-tag II- and His-tag sequence, respectively. The location of
the primers for RT-PCR is shown.
Fig. 3. In£uence of the PRM-complex to the binding capacity of
the Strep-tag II. An in vitro translation system was used to synthe-
size FABP+StII and form the corresponding PRM-complex. The
translation mixture was divided and subjected to an ultra-centrifuga-
tion and an a⁄nity chromatography. The translation products were
separated by SDS^PAGE. Shown is the autoradiogram. A: Behav-
ior of the intact PRM-complex. B: Behavior of the released protein
after addition of puromycin.
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the PRM-complex by means of His-tag a⁄nity chromatogra-
phy is achievable.
3.4. Optimizing the yield of isolated PRM-complexes
Di¡erent parameters in£uencing the yield of eluted radio-
labeled mRNA as indirect proof for the PRM-complexes were
tested on the basis of the His-tag system using mFAHis and
mFA as control.
Firstly, the translation time of a 100-Wl reaction containing
200 nM mRNA was investigated. The translations were per-
formed at 37‡C for 0, 5, 7.5, 10, 15 and 20 min. The total
amount of mRNA after translation decreased continuously
with increasing incubation time. The amount of eluted
mRNA rose up to 4.2% after 7.5 min and slightly decreased
with further incubation (Fig. 4A).
Secondly, the in£uence of ribonucleoside^vanadyl complex
(RVC), which is an e⁄cient RNase inhibitor [20], was exam-
ined. In our system, up to 0.5 mM of RVC can be used with-
out inhibiting the translation reaction. The use of RVC during
translation led only to a slight increase of total mRNA after
incubation, but the amount of eluted mRNA was always de-
creased. The best results were achieved without RVC (data
not shown).
Thirdly, we tried to reveal the in£uence of the mRNA con-
centration. Therefore, 100 Wl translation reactions containing
0.05, 0.1, 0.2, 0.4, 0.6 and 1 WM mFAHis were incubated for
8 min at 37‡C. The relation between eluted mRNA to used
mRNA was the most favorable at 0.2 WM, but the highest
number of mRNA molecules was recovered at 0.6 WM
(Fig. 4B).
Finally, the conditions of the chromatography were opti-
mized in order to decrease the background and increase the
recovered mRNA. The sample was diluted with the so-called
bu¡er to 2.5U translation volume after adding Mg(OAc)2.
The washing bu¡er for the washing steps 1^4 contained
5 mM imidazole and for the washing steps 5 and 6, 10 mM.
The combination of these results led to a low level of un-
speci¢c binding to the Ni2^IDA^agarose and increased the
yield of mFAHis after one round of a⁄nity selection up to 8%
of input mRNA as calculated by TCA precipitation of radio-
labeled mRNA (Fig. 5). The integrity of the mRNA was an-
alyzed by denaturing polyacrylamide gel electrophoresis fol-
lowed by autoradiography. As a result the amount of full
length mRNA was 5% and the background of the system
with mFA as template reached about 0.3%.
3.5. Speci¢c enrichment of a desired mRNA through multiple
rounds of selection
Before we started the test selection, identical amounts of the
two mRNAs were mixed and used for RT-PCR, followed by
transcription and another RT-PCR. None of them was fa-
vored in the RT-PCR or the transcription (data not shown).
It is a fundamental demand that the ampli¢cation between the
two species does not occur on the level of PCR.
Furthermore, di¡erent elution strategies for recovering the
mRNA were examined (Fig. 6). The elution of the PRM-com-
plex with a speci¢c competitor or a competing ligand are
useful, particularly when a special binding property has to
be selected. The mRNA can be recovered from the complexes
after adding EDTA or phenol extraction. The dissociation of
the ternary complexes with EDTA or the direct RT-PCR [21]
are also possible. These methods allow selection for high af-
Fig. 4. E¡ect of di¡erent parameters on the amount of eluted
mRNA after one cycle of ribosome display. A: In£uence of the
translation time. Total mRNA denotes the amount of mRNA after
incubation and eluted mRNA after one cycle of ribosome display in
relation to the amount of mRNA before incubation. B: In£uence of
the mRNA concentration. Eluted mRNA in percent denotes the
amount of mRNA in relation to the amount of used mRNA and
eluted mRNA in pmol the absolute amount of recovered mRNA.
Fig. 5. Analysis of mRNA during one cycle of ribosome display.
The radiolabeled mRNAs were isolated from the reaction mixtures
and the PRM-complexes before and after Ni2^IMAC. (1) Reaction
mixture, (2) reaction mixture after in vitro translation, (3) eluted
PRM-complexes. The mRNAs were separated on a 5% denaturing
polyacrylamide gel. Shown is the autoradiogram of the PAGE.
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¢nity and even covalent binders. Since we are only interested
in eluting speci¢c binders and our system is based on Ni2^
IDA^agarose the use of EDTA is excluded during the selec-
tion step. Afterwards a reasonable combination of the possi-
bilities of recovering selected mRNA molecules might be ef-
fective. Our optimized strategy combines the EDTA
dissociation and the direct RT. The eluted PRM-complexes
were ¢rstly treated with EDTA, secondly precipitated with
isopropanol and 10 Wl of the dissolved pellet were ¢nally
used for RT. The RT primer was designed to hybridize up-
stream of the 3P end of the mRNA which is possibly still
covered by the ribosome. The 3P-end of the mRNA was re-
generated during the PCR.
A mixture of two mRNAs served as a starting pool for a
selection. The goal of the selection was to bind on Ni2^IDA^
agarose. Using ribosome display a mRNA encoding a His-tag
should be enriched. Therefore, mFA and mFAHis were mixed
in di¡erent ratios and used for ribosome display. Their PCR
products di¡er slightly in length (21 bp), because of the exis-
tence of the His-tag and a linker codon, and can thus be
distinguished after agarose gel electrophoresis. Depending
on the ratio of dilution di¡erent numbers of cycles according
to Fig. 1 were necessary to enrich the PCR product encoding
FABP with His-tag (Table 1). Even when using a ratio of
1:108 (one mFAHis in relation to 10 000 000 mFA-molecules)
‘one molecule’ could be selected after nine cycles (Fig. 7). The
PCR products which went through nine cycles of selection
were cloned and analyzed. Eight out of 10 sequenced clones
had the full His-tag sequence, and the remaining two had a
shortened His-tag sequences encoding ¢ve and four histidines,
respectively (data not shown). The sequence analysis showed
that the clones contained between 5 and 13 base changes. At
the protein level, the selected clones carried between 0 and
5 exchanged amino acids. The error rate of the PCR and
therefore the diversi¢cation of the library can be increased
by error prone PCR [22] or by using a low ¢delity polymerase,
but can also be decreased by the use of a proof-reading poly-
merase.
4. Discussion
The results demonstrate that even the 108-fold enrichment
was successful. With our model system the selection of a spe-
ci¢c mRNA via the accompanying protein property was
shown. This study describes for the ¢rst time the use of a
protein possessing a binding property without being an anti-
body for ribosome display. This stands in contrast to previous
works which carried out phenotypic selection for ligand bind-
ing with antibodies. Another new feature we managed to in-
troduce was the use of an a⁄nity tag for isolating PRM-com-
plexes, thus establishing the ribosome display technique. On
the basis of our results it should be possible to do in vitro
evolution of proteins or just a special portion of them which
are optimized for other reasons than recognition and binding
target molecules. Since ribosome display is a monovalent sys-
tem the high binding a⁄nities in the low nanomolar or even
picomolar range selected so far are not always desired but
rather necessary for selecting the whole complex. Therefore,
the selection of proteins with a⁄nities in the micromolar
range is, in contrast to the multivalent phage and plasmid
display systems, not achievable. All selection steps of ribo-
some display are carried out in vitro; thus it is possible to
overcome the limitations of in vivo approaches. The library
size that can be handled correlates directly with the number of
active ribosomes in the translation mixture. The concentration
of ribosomes in our system is about 1 WM and even if only
20% of them are active it should be possible to screen libraries
of V1014 independent members.
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